A new episode of Health investigation focuses on the potential risks linked to hormonal treatments, especially Androcur, a synthetic progestin used in various medical contexts. The documentary, produced by Elise Richard, will air on France.tv starting 7 October, and on France 5 at 21h05 on 13 October. The report addresses growing concerns about a possible connection between contraceptive pills and a higher risk of developing intracranial tumors—tumors that form inside the skull. Approximately 1.6 million women are expected to receive letters informing them of this risk, highlighting the widespread use of these medications. The issue involves an entire family of hormonal treatments, many of which have been used by patients for years without clear warnings about potential health risks. Elise Richard, the documentary’s producer, discovered she had a meningioma—a type of brain tumor—after a decade of using Androcur or its generic equivalents. Her personal experience serves as the foundation for her investigation into how such a drug could be prescribed so widely and for such a long time without specific warnings. The documentary raises important questions about who was aware of these risks and why they were not communicated more clearly to patients. It also examines the broader implications of long-term use of hormonal treatments and the responsibility of healthcare providers and pharmaceutical companies in informing patients about potential dangers. Following the broadcast, a public debate will be held, hosted by Marina Carrère-d'Encausse and Enora Malagré. The discussion will feature Elise Richard, along with Professor Michel Kalamarides, Professor Sophie Catteau-Jonard, and Yann Mazens, who will provide expert insights and perspectives on the topic.